Covishield, Covaxin Get Regular Market Nod For Use In Adult Population
New Delhi: The Drugs Controller General of India (DCGI) on Thursday granted regular market approval to Serum Institute of India's (SII's) Covishield and Bharat Biotech's Covaxin for use in the adult population subject to certain conditions.…